BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
Atriva Therapeutics
/
Prof. Dr. Oliver Planz
PD
Prof. Dr. Oliver Planz
Co-founder & Chief Scientific Officer
Atriva Therapeutics
Therapeutic Areas
Infectious Disease
Respiratory
Atriva Therapeutics Pipeline
Drug
Indication
Phase
Zapnometinib (ATR-002)
Influenza
Phase 2
Leadership Team at Atriva Therapeutics
DR
Dr. Rainer Lichtenberger
Chief Executive Officer
DB
Dr. Bernhard G. Lach
Co-founder
View full Atriva Therapeutics profile